AMNOG PHARMA PRICING ANALYSIS

We analyzed the outcomes of previous Post AMNOG Price Negotiations to enable our pharma clients to improve their Market Access and Reimbursement planning.

With the AMNOG PRICING ANALYSIS we have developed a tool to give an overview of rebates negotiated after benefit assessment since 2011, based on data of the German Lauertaxe database.

You can request a download of the entire analysis free of charge.

Pharma pricing analysis amnog

Be also aware of advisors in healthcares 
AMNOG BENEFIT ASSESSMENT ANALYSIS

We developed a tool where you can see the outcomes of the benefit assessment at a glance:

Analysis and comparison of the additional benefit that was recommended by the Institute for Quality and Efficiency in Health Care (IQWiG) and then assessed by the Federal Joint Committee (G-BA) with the expectations of the manufacturers.